immediate result and long term follow-up in patients going under primary percutaneous intervention for st-elevation myocardial infarction
نویسندگان
چکیده
conclusions this study confirms that primary pci revascularization is the best treatment for the acute st elevation mi with brilliant acute result and one- year high survival and acceptable cardiac and non-cardiac complications. studying the effects of using des and bms on long term cardiac mortality, morbidity and need to target vessels revascularization (tvr) shows that performing the pci in the golden time is very important and type of stent is not much important. by reducing the expenses of this procedure through using bms, we can give this chance to more patients. results the successful rate of primary pci in this study was estimated to be 100%. mace occurred in 4 patients (5.8%) (2 deaths and 2 myocardial infarctions) and mane occurred in 8 patients (11.8%) (7 cases with major or minor bleeding and one with contrast nephropathy). in one- year follow-up of patients who included in the study, surveillance rate was 91.2 % (62 of 68), 13 patients had persistent cardiac symptoms (19.1%), 3 of them were admitted to the hospital with coronary syndromes (4.4%) and just one patients underwent target vessel revascularization (1.5%). 3 patients had to do cabg in the first year (4.4%). studying the long term mace and stent type (drug eluting stents vs. bare metal stents) revealed: death; 1 (3.6%) vs. 6 (11.5%), persistent cardiac symp; 3 (10.7) vs. 11 (21.2%), hospitalization; no patient vs. 4 (7.7%) and no tvr in drug eluting stents (des) group vs. 1 (1.9%) in bare metal stents (bms) group. background primary percutaneous intervention (pci) is the choice of reperfusion therapy and is significantly superior to thrombolysis in acute st-elevation myocardial infarction (mi). objectives we did design this study to evaluate the successful rate, early complication and late follow-up of the patients with acute myocardial infarction who referred to razavi hospital. patients and methods in this study, 68 consecutive patients who were admitted by diagnosis of acute coronary myocardial infarction and st-elevation change in ecg underwent primary pci by a single high volume operator from march, 2008 to march, 2011. the successful rate, incidence of in hospital’s main adverse cardiac effects (mace) and main adverse non-cardiac effects (mane) and also their impact on one- year cardiac mortality and morbidity were estimated.
منابع مشابه
Platelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis
Introduction: No-reflow increases the complications and mortality rate of primary percutaneous coronary intervention (PCI). Therefore, it is important to identify patients at a higher risk of developing no-reflow. This study aimed to systematically review the prognostic value of the platelet-to-lymphocyte ratio (PLR) to predict no-reflow. Materials and Methods:</s...
متن کاملOsteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
BACKGROUND Osteoprotegerin (OPG) is a glycoprotein with a regulatory role in immune, skeletal and vascular systems. Data suggest that high circulating OPG levels are associated with an increased risk of cardiovascular disease. We analyzed the association between OPG and long-term outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous corona...
متن کاملGender and Age Differences in Short- and Long-Term Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
BACKGROUND Studies have reported that women with ST elevation myocardial infarction (STEMI) have worse short- and long-term outcomes than men. It has not yet been confirmed whether these differences reflect differences in age between men and women. METHODS We retrospectively enrolled 1035 consecutive STEMI patients treated with primary percutaneous coronary intervention (PCI). Baseline clinic...
متن کاملComparison of the Success Rate of Treatment with Primary Percutaneous Coronary Intervention PCI versus Thrombolytic Treatment in Patients with ST-Elevation Myocardial Infarction in Local Hospitals in Iran
Background and Objective: Acute myocardial infarction (MI) is caused due to coronary artery occlusion and divided into two forms of ST-elevation (STEMI) and non-ST-elevation (NSTEMI) myocardial infarction. This study aimed to determine the success rate of treatment with primary PCI (percutaneous coronary intervention) versus thrombolysis in the establishment of perfusion and to evaluate the sho...
متن کاملLong-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly
BACKGROUND The population is ageing rapidly and the proportion of patients aged ≥ 80 years undergoing primary percutaneous coronary intervention (PCI) is rising, but clinical trials have primarily been performed in younger patients. METHODS Patients undergoing primary PCI between 2003 and 2008 were subdivided into 3 groups: < 60, 60-79, and ≥ 80 years. Endpoints at 3-year follow-up included a...
متن کاملNo-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors
Introduction: No-reflow phenomenon in coronary vessels, manifested in some patients with reperfused acute myocardial infarction (MI), is associated with poor clinical and functional outcomes. Therefore, evaluation of predisposing risk factors can be helpful in risk assessment and identification of patients at higher risk. Herein, we aimed to study the predictive factors for the development of...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
razavi international journal of medicineجلد ۲، شماره ۳، صفحات ۰-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023